Nuwellis (formerly CHF Solutions) is a Delaware incorporated company that trades on NASDAQ under the ticker NUWE (formerly CHFS).
To assist all shareholders of Nuwellis, a list of Frequently Asked Questions are set out below.
Important Notice: The information in this document does not take into account your individual investment objectives, financial situation and needs. The information in this document is of a general nature and is not financial product advice and should not be relied upon as the sole basis for any investment decision. Shareholders should consult their financial, legal or tax adviser before deciding to buy or sell shares in Nuwellis.
Nuwellis is traded on the NASDAQ under the stock symbol of NUWE.
Nuwellis has been listed on the Nasdaq Capital Market since February 2012, previously branded as CHF Solutions (Nasdaq:CHFS).
Sunshine Heart was previously listed on the Australian Stock Exchange (ASX). On February 5, 2013, we received conditional approval from the ASX to delist from the official list of the ASX. The official delisting occurred at the close of trading on May 6, 2013.
No. Nuwellis does not currently issue dividends on common stock or have a DRIP.
Please contact our transfer agent, American Stock Transfer & Trust Company (AST). Shareholders can call AST customer service at 1-800-937-5449 for transfers, address changes, or any other questions regarding their Nuwellis stock certificates.
Additionally, shareholders can mail correspondence to AST at the following address:
AST – Operations Center
6201 15th Avenue
Brooklyn, NY 11219
The Corporate and Investor Relations contact information is as follows:
You can also contact us through our online investor IR Contact Information form.